Literature DB >> 3006660

The gamma-aminobutyrate/benzodiazepine receptor from pig brain. Enhancement of gamma-aminobutyrate-receptor binding by the anaesthetic propanidid.

E F Kirkness, A J Turner.   

Abstract

The binding of [3H]muscimol, a gamma-aminobutyrate (GABA) receptor agonist, to a membrane preparation from pig cerebral cortex was enhanced by the anaesthetic propanidid in a concentration-dependent manner. At 0 degrees C, binding was stimulated to 220% of control values, with 50% stimulation at 60 microM-propanidid. At 37 degrees C, propanidid caused a more powerful stimulation of [3H]muscimol binding (340% of control values). Propanidid (1 mM) exerted little effect on the affinity of muscimol binding (KD approx. 10 nM), but increased the apparent number of high-affinity binding sites in the membrane by 2-fold. Enhancement of [3H]muscimol binding was observed only in the presence of Cl- ions, half-maximal activation being achieved at approx. 40 mM-Cl-. Picrotoxinin inhibited the stimulation of [3H]muscimol binding by propanidid with an IC50 (concentration causing 50% inhibition) value of approx. 25 microM. The enhancement of [3H]muscimol binding by propanidid was not additive with the enhancement produced by secobarbital. Phenobarbital inhibited the effect of propanidid and secobarbital. The GABA receptor was solubilized with Triton X-100 or with Chaps [3-[(3-cholamidopropyl)dimethylammonio]propanesulphonate]. Propanidid and secobarbital did not stimulate the binding of [3H]muscimol after solubilization with Triton X-100. However, the receptor could be solubilized by 5 mM-Chaps with retention of the stimulatory effects of propanidid and secobarbital. Unlike barbiturates, propanidid did not stimulate the binding of [3H]flunitrazepam to membranes. It is suggested that the ability to modulate the [3H]muscimol site of the GABA-receptor complex may be a common and perhaps functional characteristic of general anaesthetics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006660      PMCID: PMC1153013          DOI: 10.1042/bj2330259

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Solubilization of gamma-aminobutyric acid receptor protein from mammalian brain.

Authors:  D V Greenlee; R W Olsen
Journal:  Biochem Biophys Res Commun       Date:  1979-05-28       Impact factor: 3.575

2.  In vitro modulation by SQ 20009 and SQ 65396 of GABA receptor binding in rat CNS membranes.

Authors:  P Placheta; M Karobath
Journal:  Eur J Pharmacol       Date:  1980-03-21       Impact factor: 4.432

3.  A comparison of the actions of pentobarbitone and etomidate on [3H]GABA binding to crude synaptosomal rat brain membranes.

Authors:  M Willow
Journal:  Brain Res       Date:  1981-09-14       Impact factor: 3.252

Review 4.  GABA-benzodiazepine-barbiturate receptor interactions.

Authors:  R W Olsen
Journal:  J Neurochem       Date:  1981-07       Impact factor: 5.372

5.  Etomidate stereospecifically stimulates forebrain, but not cerebellar, 3H-diazepam binding.

Authors:  D Ashton; R Geerts; C Waterkeyn; J E Leysen
Journal:  Life Sci       Date:  1981-12-21       Impact factor: 5.037

6.  Solubilization of histamine H-1, GABA and benzodiazepine receptors.

Authors:  M Gavish; R S Chang; S H Snyder
Journal:  Life Sci       Date:  1979-08-27       Impact factor: 5.037

7.  Chloride-dependent stimulation of GABA and benzodiazepine receptor binding by pentobarbital.

Authors:  T Asano; N Ogasawara
Journal:  Brain Res       Date:  1981-11-23       Impact factor: 3.252

8.  Dual action of pentobarbitone on GABA binding: role of binding site integrity.

Authors:  M Willow; G A Johnston
Journal:  J Neurochem       Date:  1981-11       Impact factor: 5.372

9.  Diazepam and (--)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons.

Authors:  R E Study; J L Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Barbiturate receptor sites are coupled to benzodiazepine receptors.

Authors:  F Leeb-Lundberg; A Snowman; R W Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  7 in total

1.  An electrophysiological investigation of the characteristics and function of GABAA receptors on bovine adrenomedullary chromaffin cells.

Authors:  J A Peters; J J Lambert; G A Cottrell
Journal:  Pflugers Arch       Date:  1989-10       Impact factor: 3.657

2.  Additivities of compounds that increase the numbers of high affinity [3H]muscimol binding sites by different amounts define more than 9 GABA(A) receptor complexes in rat forebrain: implications for schizophrenia and clozapine research.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  2000-12       Impact factor: 3.996

3.  The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones.

Authors:  T G Hales; J J Lambert
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

Review 4.  Understanding the GABAA receptor: a chemically gated ion channel.

Authors:  F A Stephenson
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

5.  The concept of isoreceptors: application to the nicotinic acetylcholine receptor and the gamma-aminobutyric acidA/benzodiazepine receptor complex.

Authors:  J Hebebrand; W Friedl; P Propping
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

6.  The gamma-aminobutyrate/benzodiazepine receptor from pig brain. Purification and characterization of the receptor complex from cerebral cortex and cerebellum.

Authors:  E F Kirkness; A J Turner
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

Review 7.  Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy.

Authors:  Slobodan M Janković; Miralem Dješević; Snežana V Janković
Journal:  J Exp Pharmacol       Date:  2021-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.